Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$376,543
-$79,633 QoQ
Shares Held
4,770
-14.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 91%
Shared 8%
None 1%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $3,593,465,193 across 39 Diagnostics & Research names. BLLN ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,913,903 | $1,923,800,734 | |
| 2 | DHR |
Danaher Corp /De/
|
3,299,528 | $625,590,502 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
391,704 | $220,094,556 | |
| 4 | LH |
Labcorp Holdings Inc.
|
820,442 | $218,902,126 | |
| 5 | A |
Agilent Technologies, Inc.
|
828,773 | $94,463,542 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
401,428 | $68,459,527 | |
| 7 | WAT |
Waters Corp /De/
|
228,857 | $68,153,609 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
123,929 | $59,509,461 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $376,543 | 4,770 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $456,176 | 5,574 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||